[1]孙天慧,谭晓霞,连晓芬,等.2型糖尿病合并视网膜病变的影响因素分析[J].医学信息,2020,33(21):94-96.[doi:10.3969/j.issn.1006-1959.2020.21.027]
　SUN Tian-hui,TAN Xiao-xia,LIAN Xiao-fen,et al.Analysis of Influencing Factors of Type 2 Diabetes with Retinopathy[J].Medical Information,2020,33(21):94-96.[doi:10.3969/j.issn.1006-1959.2020.21.027]
点击复制

2型糖尿病合并视网膜病变的影响因素分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年21期
页码:
94-96
栏目:
临床研究
出版日期:
2020-11-01

文章信息/Info

Title:
Analysis of Influencing Factors of Type 2 Diabetes with Retinopathy
文章编号:
1006-1959（2020）21-0094-03
作者:
孙天慧; 谭晓霞; 连晓芬; 等
（1.安徽医科大学临床医学系，安徽 合肥 230032；2.汕头大学医学院临床医学系，广东 汕头 515041；3.北京大学深圳医院内分泌科，广东 深圳 518036）
Author(s):
SUN Tian-hui; TAN Xiao-xia; LIAN Xiao-fen; et al
(1.Department of Clinical Medicine,Anhui Medical University,Hefei 230032,Anhui,China;2.Department of Clinical Medicine,Shantou University Medical College,Shantou 515041,Guangdong,China;3.Department of Endocrinology,Peking University Shenzhen Hospital,Shenzhen 518036,Guangdong,China)
关键词:
2型糖尿病; 糖尿病视网膜病变; 影响因素
Keywords:
Type 2 diabetes; Diabetic retinopathy; Influencing factors
分类号:
R587.2
DOI:
10.3969/j.issn.1006-1959.2020.21.027
文献标志码:
A
摘要:
目的 探究2型糖尿病（T2DM）合并视网膜病变患病状况及其相关因素。方法 回顾性分析2019年1~12月在北京大学深圳医院内分泌科收治的500例T2DM患者临床资料，根据是否合并糖尿病视网膜病变分为NDR组和DR组，比较两组一般资料，并采用Logistic回归分析T2DM合并视网膜病变的风险因素。结果 500例T2DM患者中合并糖尿病视网膜病变患者共123例，占比24.60%。DR组病程、HbA1c、Cr水平均高于NDR组，差异有统计学意义（P＜0.05）；两组性别、年龄、BMI、FBG、2h PBG、TG、TC、HDL-C、LDL-C、ALT、UA比较，差异无统计学意义（P＞0.05）。二分类Logistic回归分析显示，病程、HbA1c、Cr是糖尿病视网膜病变的危险因素（P＜0.05）。结论 T2DM患者糖尿病病程越长、血脂越高、肾功能不全时合并糖尿病视网膜病变的风险越高，定期进行眼科检查和控制血脂有助于糖尿病视网膜病变的干预和治疗。
Abstract:
Objective To explore the prevalence and related factors of type 2 diabetes (T2DM) combined with retinopathy.Methods The clinical data of 500 T2DM patients admitted to the Department of Endocrinology, Peking University Shenzhen Hospital from January to December 2019 were retrospectively analyzed. According to whether they had diabetic retinopathy, they were divided into NDR group and DR group. The general data of the two groups were compared and Logistic regression was used. To analyze the risk factors of T2DM with retinopathy.Results There were 123 patients with diabetic retinopathy in 500 T2DM patients, accounting for 24.60%. The course of disease, HbA1c, and Cr levels in the DR group were higher than those in the NDR group,the difference was statistically significant (P<0.05);There was no significant difference in gender, age, BMI, FBG, 2h PBG, TG, TC, HDL-C, LDL-C, ALT, UA between the two groups (P>0.05). The binary Logistic regression analysis showed that the course of disease, HbA1c and Cr were risk factors for diabetic retinopathy (P<0.05).Conclusion The longer the course of diabetes in T2DM patients, the higher the blood lipids, and the higher the risk of diabetic retinopathy when renal insufficiency was combined. Regular eye examinations and blood lipid control were helpful to the intervention and treatment of diabetic retinopathy.

参考文献/References:

[1]Jencia Wong,邢玉微,许樟荣.青少年发病的2型糖尿病:挑战和临床思考[J].临床荟萃,2019,34(11):1022-1025.[2]Saeedi P,Petersohn I,Salpea P,et al.Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045:Results from the International Diabetes Federation Diabetes Atlas,9th edition[J].Diabetes Res Clin Pract,2019(157):107843. [3]Global Burden of Disease Cancer Collaboration,Fitzmaurice C,Abate D,et al.Global,Regional,and National Cancer Incidence,Mortality,Years of Life Lost,Years Lived With Disability,and Disability-Adjusted Life-Years for 29 Cancer Groups,1990 to 2017:A Systematic Analysis for the Global Burden of Disease Study[J].JAMA Oncol,2019,5(12):1749-1768. [4]钱荣立.关于糖尿病的新诊断标准与分型[M].中国糖尿病杂志,2000,8(1):5-6[5]中华医学会糖尿病学分会.中国2型糖尿病防治指南（2017年版）[J].中华糖尿病杂志,2018,10(1):4-67.[6]Wilkinson CP,FerrisFL 3rd,Klein RE,et al.Global Diabetic Retinopathy Project G:Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales[J].Ophthalmology,2003,110(9):1677-1682.[7]Passam FH,Sfiridaki A,Pappa C,et al.Angiogenesis-related growth factors and cytokines in the serum of patients with B non-Hodgkin lymphoma;relation to clinical features and response to treatment[J].Int J Lab Hematol,2008,30(1):17-25.[8]宋婷婷.2型糖尿病患者不同病程临床特点分析[D].天津医科大学,2016.[9]陈秀华,汪耀,韩秀婕,等.老年2型糖尿病患者颈动脉粥样硬化与相关危险因素分析[J].中华糖尿病杂志,2009,1(3):186-190.[10]高丽涛,柳力敏,张媛媛,等.糖尿病视网膜病变的危险因素分析[J].眼科新进展,2011(31):742-744.

相似文献/References:

[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
　HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in Patients with Type 2 Diabetes Mellitus[J].Medical Information,2018,31(21):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
　DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Medical Information,2018,31(21):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
　CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Medical Information,2018,31(21):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(21):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]郭 明,郑继伟,马丽平.25(OH)D3与糖尿病视网膜病变的关系研究[J].医学信息,2018,31(08):99.[doi:10.3969/j.issn.1006-1959.2018.08.031]
　GUO Ming,ZHENG Ji-wei,MA Li-ping.Study on the Relationship between 25(OH)D3 and Diabetic Retinopathy[J].Medical Information,2018,31(21):99.[doi:10.3969/j.issn.1006-1959.2018.08.031]
[6]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
　LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Medical Information,2018,31(21):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[7]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
　GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Medical Information,2022,35(21):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[8]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
　XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Medical Information,2022,35(21):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[9]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
　YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Medical Information,2022,35(21):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[10]张剑君.2型糖尿病参与血管衰老的机制[J].医学信息,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
　ZHANG Jian-jun.The Mechanism of Type 2 Diabetes Mellitus in Vascular Aging[J].Medical Information,2022,35(21):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
[11]李 娟,冯双双,康京京,等.尿β2微球蛋白水平与2型糖尿病患者视网膜病变和肾脏病变的相关性[J].医学信息,2020,33(19):99.[doi:10.3969/j.issn.1006-1959.2020.19.029]
　LI Juan,FENG Shuang-shuang,KANG Jing-jing,et al.Correlation Between Urine β2 Microglobulin Level and Retinopathy and Nephropathy in Type 2 Diabetic Patients[J].Medical Information,2020,33(21):99.[doi:10.3969/j.issn.1006-1959.2020.19.029]
[12]马 斌,王彩星,王金虹.基于文献计量学的我国2型糖尿病护理研究现状及热点分析[J].医学信息,2021,34(22):12.[doi:10.3969/j.issn.1006-1959.2021.22.004]
　MA Bin,WANG Cai-xing,WANG Jin-hong.Analysis of Current Status and Hot Spots in Nursing Research of Type 2 Diabetes Mellitus in China Based on Bibliometrics[J].Medical Information,2021,34(21):12.[doi:10.3969/j.issn.1006-1959.2021.22.004]
[13]李 莎,姜 崴.2型糖尿病视网膜病变患者血清ANGPTL8的水平及临床意义[J].医学信息,2024,37(07):93.[doi:10.3969/j.issn.1006-1959.2024.07.017]
　LI Sha,JIANG Wei.The Level and Clinical Significance of Serum ANGPTL8 in Patients with Type 2 Diabetic Retinopathy[J].Medical Information,2024,37(21):93.[doi:10.3969/j.issn.1006-1959.2024.07.017]

更新日期/Last Update: 1900-01-01